Does Late Levodopa Administration Delay the Development of Dyskinesia in Patients with De Novo Parkinson’s Disease?

被引：0
|
作者：
Seok Jong Chung
Han Soo Yoo
Hye Sun Lee
Hyo Eun Jeong
Soo-Jong Kim
Jungsu S. Oh
Jae Seung Kim
Young H. Sohn
Phil Hyu Lee
机构：
[1] Yonsei University College of Medicine,Department of Neurology
[2] Yonsei University College of Medicine,Department of Biostatistics
[3] Yonsei University College of Medicine,Department of Family Medicine
[4] University of Ulsan College of Medicine,Department of Nuclear Medicine, Asan Medical Center
[5] Yonsei University College of Medicine,Severance Biomedical Science Institute
来源：
CNS Drugs | 2018年 / 32卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：971 / 979
页数：8
相关论文
共 50 条
  • [1] Does Late Levodopa Administration Delay the Development of Dyskinesia in Patients with De Novo Parkinson's Disease?
    Chung, Seok Jong
    Yoo, Han Soo
    Lee, Hye Sun
    Jeong, Hyo Eun
    Kim, Soo-Jong
    Oh, Jungsu S.
    Kim, Jae Seung
    Sohn, Young H.
    Lee, Phil Hyu
    CNS DRUGS, 2018, 32 (10) : 971 - 979
  • [2] Effect of levodopa on depression in de novo patients with Parkinson's disease
    Kashihara, K.
    Imamura, T.
    Ohno, M.
    MOVEMENT DISORDERS, 2013, 28 : S145 - S146
  • [3] The efficacy of the levodopa on cognitive function in patients with de novo Parkinson's disease
    Kobayashi, Y
    Hozumi, A
    Tanaka, H
    Arai, M
    Hirata, K
    DEVELOPMENTS IN NEUROSCIENCES, 2004, 1259 : 357 - 361
  • [4] Nonmotor Predictors for Levodopa Requirement in De Novo Patients With Parkinson's Disease
    Erro, Roberto
    Picillo, Marina
    Amboni, Marianna
    Moccia, Marcello
    Vitale, Carmine
    Longo, Katia
    Pellecchia, Maria Teresa
    Santangelo, Gabriella
    Martinez-Martin, Pablo
    Chaudhuri, K. Ray
    Barone, Paolo
    MOVEMENT DISORDERS, 2015, 30 (03) : 373 - 378
  • [5] COULD CARDIAC SYMPATHETIC DENERVATION PREDICT LEVODOPA-INDUCED DYSKINESIA IN DE NOVO PARKINSON'S DISEASE?
    Kang, S. -J.
    Ahn, J. Y.
    Kim, H. -T.
    PARKINSONISM & RELATED DISORDERS, 2018, 46 : E76 - E76
  • [6] Parjupar study: Bromocriptine or selegiline, or both, to delay the need of levodopa therapy in de novo Parkinson's disease patients
    CastroCaldas, A
    Sampaio, C
    Botelho, MA
    Gouveia, A
    NEUROLOGY, 1996, 46 (02) : 5122 - 5122
  • [7] Influence of the levodopa on frontal lobe dysfunction in patients with de novo Parkinson's disease
    Kobayashi, Y
    Hirata, K
    Hozumi, A
    Tanaka, H
    Arai, M
    Kaji, Y
    Kadowaki, T
    Daimon, Y
    FRONTIERS IN HUMAN BRAIN TOPOGRAPHY, 2004, 1270 : 270 - 274
  • [8] Does levodopa therapy delay death in Parkinson's disease?
    Uitti, RJ
    Ahlskog, JE
    Maraganore, DM
    MOVEMENT DISORDERS, 1996, 11 (03) : 343 - 344
  • [9] Presynaptic dopamine depletion predicts levodopa-induced dyskinesia in de novo Parkinson disease
    Hong, Jin Yong
    Oh, Jungsu S.
    Lee, Injoo
    Sunwoo, Mun Kyung
    Ham, Jee Hyun
    Lee, Ji E.
    Sohn, Young H.
    Kim, Jae Seung
    Lee, Phil Hyu
    NEUROLOGY, 2014, 82 (18) : 1597 - 1604
  • [10] The effect of levetiracetam on levodopa induced dyskinesia in patients with Parkinson's disease
    Tousi, B
    Subramanian, T
    PARKINSONISM & RELATED DISORDERS, 2005, 11 (05) : 333 - 334
12345